Literature DB >> 3599657

Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism.

P Patron, J P Gardin, M Paillard.   

Abstract

We studied circulating 1,25(OH)2D3 and its determinants in 102 patients with primary hyperparathyroidism (PHPT), 33 of them with recurrent renal stones, 60 with non-specific symptoms, and nine with overt bone disease. Means for serum 1,25(OH)2D3 and intestinal absorption of calcium were abnormally high in the renal stone group, slightly elevated in the non-specific group, and low-normal in the bone disease group. In the whole population of patients, we found a positive correlation between circulating 1,25(OH)2D3 and creatinine clearance (taken as an index of the functional renal mass). Negative correlations were observed between 1,25(OH)2D3 and age, and between creatinine clearance and age, the latter being not different from that observed in a normal large population. In the renal stone group, means for the determinants of the renal 1 alpha hydroxylase activity, that is, PTH activity expressed as nephrogenous cyclic AMP (NcAMP), serum phosphate and calcium were identical to those of the group with non-specific symptoms. However means for age were lower and functional renal mass significantly higher in the renal stone group, which may account for the higher value of circulating 1,25(OH)2D3. In the bone disease group, means for age, renal mass and serum calcium were identical to those of the group with non-specific symptoms, and NcAMP was far higher and hypophosphatemia more marked, which may not account for the lower value of circulating 1,25(OH)2D3. However, in the bone disease group, serum 25(OH)D was abnormally low, which may limit the renal production of 1,25(OH)2D3 and explain the low-normal circulating values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3599657     DOI: 10.1038/ki.1987.125

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

Review 1.  Clinical spectrum of primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

Review 3.  "Asymptomatic" and symptomatic primary hyperparathyroidism.

Authors:  J A Fischer
Journal:  Clin Investig       Date:  1993-07

4.  Risk factors associated to kidney stones in primary hyperparathyroidism.

Authors:  S Corbetta; A Baccarelli; A Aroldi; L Vicentini; G B Fogazzi; C Eller-Vainicher; C Ponticelli; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

Review 5.  Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Bridget Sinnott
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

6.  Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison.

Authors:  G Cadiot; P Houillier; A Allouch; M Paillard; M Mignon
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Brown jaw tumors: today's unusual presentation of primary hyperparathyroidism.

Authors:  S Corbetta; D Rossi; O D'Orto; L Vicentini; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

8.  The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption.

Authors:  M L Farias; A G Delgado; D Rosenthal; J G Vieira; T Kasamatsu; M J Lazarevitch; M F Pereira; M B Lima
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

Review 9.  Causes and prevention of calcium-containing renal calculi.

Authors:  R A Sutton
Journal:  West J Med       Date:  1991-09

10.  Biochemical characterization of primary hyperparathyroidism with and without kidney stones.

Authors:  Clarita V Odvina; Khashayar Sakhaee; Howard J Heller; Roy D Peterson; John R Poindexter; Paulette K Padalino; Charles Y C Pak
Journal:  Urol Res       Date:  2007-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.